Lineage Cell Therapeutics, Inc.·4

Nov 25, 4:30 PM ET

Mulroy Michael H. 4

4 · Lineage Cell Therapeutics, Inc. · Filed Nov 25, 2024

Insider Transaction Report

Form 4
Period: 2024-11-22
Transactions
  • Purchase

    Common Shares

    2024-11-22$0.57/sh+40,000$22,640298,555 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4